Approved by the FDA as a rheumatoid arthritis medication, Xeljanz may have a second life as a drug used to treat moderate to severe eczema after initial studies show exciting results.
Approved by the FDA as a rheumatoid arthritis medication, Xeljanz may have a second life as a drug used to treat moderate to severe eczema after initial studies show exciting results.